By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Shionogi & Co., Ltd. 

1-8, Doshomachi 3-Chome
Chuo-ku
Osaka     541-0045  Japan
Phone: 81-0-6-6202-2161 Fax: 81-0-6-6229-9596


SEARCH JOBS



Segment
Research





Company News
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test 7/11/2012 6:44:43 AM
Shionogi & Co., Ltd. and Shionogi, Inc. Announce a Favorable Decision In FORTAMET® Preliminary Injunction Proceedings 12/7/2011 8:43:56 AM
Shire plc Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd. 11/18/2011 10:38:15 AM
MorphoSys AG and Shionogi & Co., Ltd. Agree Three-Year Extension of Research Partnership 11/2/2011 8:37:48 AM
Evotec AG (EVTG.F) Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi & Co., Ltd. 10/27/2011 10:16:12 AM
Japan's Shionogi & Co., Ltd. to Acquire C&O Pharmaceutical Technology for About $182 Million 8/1/2011 8:05:28 AM
Shionogi & Co., Ltd. Announces Commercial Availability of CUVPOSA(TM) (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 4/7/2011 6:31:09 AM
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Collaboration with Shionogi & Co., Ltd. 3/30/2011 9:22:32 AM
Biocryst Pharmaceuticals (BCRX)'s Partner Shionogi & Co., Ltd. Receives Approval for Pediatric Use Of Flu Drug Peramivir in Japan 10/27/2010 8:23:35 AM
Shionogi & Co., Ltd. Announces Reorganization of US Operations, New Leadership; New CEO Named 7/1/2010 11:28:36 AM
123456
//-->